NCT02327169 2020-02-25A Study MLN2480 in Combination With MLN0128 or Alisertib, or Paclitaxel, or Cetuximab, or Irinotecan in Adult Participants With Advanced Nonhematologic MalignanciesTakedaPhase 1 Completed81 enrolled 33 charts
NCT01899053 2019-10-30A Safety and Pharmacokinetic Study of TAK-228 in Combination With TAK-117 in Adult Participants With Advanced Nonhematologic MalignanciesTakedaPhase 1 Completed101 enrolled 54 charts